New Markers of Inflammation and Endothelial Cell Activation (Q28211342)

title

New markers of inflammation and endothelial cell activation: Part I (English)

0 references

New Markers of Inflammation and Endothelial Cell Activation (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

23 March 2024

0 references

0 references

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

23 March 2024

author name string

Chao-Hung Wang

2

0 references

Subodh Verma

6

0 references

Paul E. Szmitko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568885

23 March 2024

Richard D. Weisel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568885

23 March 2024

John R. de Almeida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568885

23 March 2024

Todd J. Anderson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568885

Primary endothelial dysfunction: atherosclerosis

23 March 2024

language of work or name

English

0 references

publication date

21 October 2003

0 references

published in

Circulation

0 references

volume

108

0 references

issue

16

0 references

page(s)

1917-23

0 references

cites work

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Endothelial function. From vascular biology to clinical applications

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Atherosclerosis — An Inflammatory Disease

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Inflammation in atherosclerosis

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

23 March 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

The L-arginine-nitric oxide pathway

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide

23 March 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

23 March 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

23 March 2024

24

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor

23 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Innate and adaptive immunity in the pathogenesis of atherosclerosis

23 March 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells

23 March 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

23 March 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.

23 March 2024

30

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

23 March 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Thrombin signalling and protease-activated receptors

23 March 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

23 March 2024

33

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

23 March 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone.

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Coming of age of C-reactive protein: using inflammation markers in cardiology

23 March 2024

39

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

23 March 2024

41

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

CD40-CD40L interactions in atherosclerosis

23 March 2024

43

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system

23 March 2024

44

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

23 March 2024

45

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

23 March 2024

47

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

23 March 2024

48

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells.

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative

23 March 2024

51

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Soluble CD40 Ligand in Acute Coronary Syndromes

23 March 2024

53

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones

23 March 2024

55

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

23 March 2024

56

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation

23 March 2024

57

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species

23 March 2024

58

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

23 March 2024

59

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

23 March 2024

60

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.

23 March 2024

61

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

CD40 ligation induces tissue factor expression in human vascular smooth muscle cells

23 March 2024

62

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.

23 March 2024

63

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Cloning of a new cytokine that induces IFN-gamma production by T cells

23 March 2024

64

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

23 March 2024

65

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.

23 March 2024

66

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

23 March 2024

67

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Interleukin-18 regulates both Th1 and Th2 responses

23 March 2024

68

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

23 March 2024

69

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

23 March 2024

71

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris

23 March 2024

72

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways

23 March 2024

75

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Chemoattraction of Human T Cells by IL-18

23 March 2024

76

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

23 March 2024

77

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000089190.95415.9F